ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 220 filers reported holding ALKERMES PLC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $26,000 | – | 1,325 | +132400.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q3 2019 | $111,000 | +484.2% | 5,683 | +588.8% | 0.00% | – |
Q2 2019 | $19,000 | -42.4% | 825 | -25.7% | 0.00% | – |
Q4 2018 | $33,000 | -96.1% | 1,110 | -94.4% | 0.00% | -100.0% |
Q3 2018 | $842,000 | -70.4% | 19,821 | -71.3% | 0.01% | -64.7% |
Q2 2018 | $2,840,000 | +354.4% | 68,999 | +513.8% | 0.02% | +183.3% |
Q4 2016 | $625,000 | -74.6% | 11,241 | -84.4% | 0.01% | -87.2% |
Q1 2016 | $2,460,000 | – | 71,969 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |